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A disproportionate number of Greenland’s Inuit population are chronically infected with
Hepatitis B virus (HBV; 5–10%). HBV genotypes B and D are most prevalent in the
circumpolar Arctic. Here, we report 39 novel HBV/D sequences from individuals residing
in southwestern Greenland. We performed phylodynamic analyses with ancient HBV
DNA calibrators to investigate the origin and relationship of these taxa to other HBV
sequences. We inferred a substitution rate of 1.4 × 10−5 [95% HPD 8.8 × 10−6, 2.0 ×
10−5] and a time to the most recent common ancestor of 629 CE [95% HPD 37–1138
CE]. The Greenland taxa form a sister clade to HBV/D2 sequences, specifically New
Caledonian and Indigenous Taiwanese sequences. The Greenland sequences share
amino acid signatures with subgenotypes D1 and D2 and ∼97% sequence identity. Our
results suggest the classification of these novel sequences does not fit within the current
nomenclature. Thus, we propose these taxa be considered a novel quasi-subgenotype.
Keywords: evolution, HBV, phylogenetics, phylogenomics, hepatitis
1. INTRODUCTION
Hepatitis B virus (HBV) is an ancient virus that remains a substantial public health burden.
Transmitted by bodily fluid, it is one of the most prevalent viruses in the world, infecting over 2
billion people, 257 million of whom are chronically infected (WHO, 2019).
HBV is classified into nine distinct genotypes (A through I) and a putative 10th genotype (J)
(Kramvis, 2014). Precedent sorting of genotype identity is calculated by a distance-based sequence
threshold of 8% (Okamoto et al., 1988; Zhou and Holmes, 2007; Locarnini et al., 2013; Araujo,
2015; Lin and Kao, 2015; Littlejohn et al., 2016). Subgenotypes are traditionally assigned based on
a 4–7.5% threshold across the full genome (McNaughton et al., 2020), though new phylogenetic
inference methods to determine subgenotype have been suggested (Yin et al., 2019). McNaughton
et al. (2020) notes that all genotypes have subgenotype sequence divergence rates of 3–8%, with the
exception of genotype D, which is 2–4%, indicating a lack of long evolutionary branches separating
well-defined clades. Recent suggestions for HBV taxonomic nomenclature include assigning the
term “quasi-subgenotype” to a lineage that does notmeet the criteria nor clearly belongs to a defined
subgenotype based on <4% nucleotide divergence among complete genomes following detailed
phylogenetic analysis (Pourkarim et al., 2010).
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HBV was considered hyperendemic in the western
circumpolar Arctic (Alaska, Canada, and Greenland) before the
introduction of HBV vaccination programs (Lavanchy, 2008)
with the burden of viral hepatitis disproportionately borne
by Indigenous populations. Prior to the introduction of HBV
vaccination programs in the Canadian Arctic in the 1990s,
HBV prevalence was ∼3% among Inuit populations (Osiowy
et al., 2013); moreover, the risk of lifetime exposure to HBV was
25% or five times higher than the non-Indigenous population
(Tulisov et al., 2007). Approximately 5–10% of Greenland’s Inuit
population remains chronically infected with HBV (Børresen
et al., 2011; Rex et al., 2015). Since 1965, serosurveys of HBV
exposure among Greenland residents have demonstrated high
rates of exposure among adults and chronic infection rates 14–40
times higher than the US and northern Europe (Tulisov et al.,
2007). Genotypes B and D predominate in the North American
circumpolar Arctic (Osiowy et al., 2013). Western Greenland’s
infections are represented by two genotypes: a majority genotype
D and a minority genotype A (Osiowy et al., 2013). While
infancy is regarded as the most receptive stage of HBV infection,
the incidence of active infection increases in adolescence
(Tulisov et al., 2007). This highlights transmission by sexual
contact, which is the primary method for HIV transmission in
Greenland (Bjorn-Mortensen et al., 2013).
The most prevalent and endemic subgenotype, B5 (formerly
B6), within the Alaska Native and Inuit populations of the
western circumpolar Arctic may have originated coincident with
the rapid movement of the Thule from regions of Alaska to
the eastern Arctic (Bouckaert et al., 2017) ∼1,000 years before
present (YBP). Greenland Inuit harboring genotype D HBV
(HBV/D) infections, such as those discussed in this study, may
represent another endemic lineage with high rates of chronic
infection and, importantly, a unique coalescent origin from other
defined HBV/D subgenotypes. Known presence of HBV/D in
the Arctic is limited to Greenland (Langer et al., 1997), Western
Canada, and Alaska (Livingston et al., 2007; Osiowy et al., 2011).
Association of HBV/D with First Nation Dene living in the
western Arctic has also been observed, suggesting a separate
introduction from Greenlandic Inuit (Osiowy et al., 2011).
Additionally, Inuit residing in the Canadian Arctic infected
with subgenotype HBV/B5 experience less severe clinical
outcomes typical of non-Indigenous people infected with other
HBV/B subgenotypes (Minuk and Uhanova, 2003). This reduced
risk phenomenon for Inuit infected with HBV/D is unknown.
Historically, genotype D has poorer clinical prognoses and
a lower response to therapy (McMahon, 2008; Yin et al.,
2019). Specific basal core promoter (BCP) nucleotide mutations,
T1762 and A1764, are important markers associated with
liver disease progression and development of hepatocellular
carcinoma (HCC) (Yang et al., 2016), and they are highly
associated with HBV/D (Lin and Kao, 2015).
Despite its broad geographical distribution and large volume
of sequence data, the evolutionary history of HBV remains
ambiguous. The difference in substitution rates depending
on whether the infection is acute, chronic, or within-vs.-
between hosts (Vrancken et al., 2014) is compounded by
discrepant calibrations (i.e., fossil-based or tip-dated). Ancient
DNA (aDNA) calibration for exogenous viruses has been
shown to tease apart some of the evolutionary mystery of
HBV (Mühlemann et al., 2018), revealing a surprising lack of
temporal genetic change in the last half millennium (Krause-
Kyora et al., 2018). HBV is a suitable candidate for aDNA
external calibration because of its high viremic levels, even during
periods of prolonged infection, and covalently closed circular
DNA (cccDNA) genome structure (Kramvis, 2014).
In this study, we report 39 novel Greenland taxa and
investigate their phylogenetic relationships and the time to
the most recent common ancestor (TMRCA) of HBV/D in
Greenland. To understand how and when HBV reached Inuit
populations, we analyzed novel sequence data combined with
publicly available datasets and ancestral sequences. Here, we
investigate the Greenland clade’s genetic composition and




Thirty-nine serum specimens were collected from 25 individuals
infected with HBV from five settlements in Western Greenland:
Aasiaat, Itilleq, Nuuk, Sarfannguaq, and Sisimiut (Figure 1), as
previously described (Kowalec et al., 2013; Bouckaert et al., 2017)
(Supplementary Table 1). In certain cases, consecutive paired
sera separated 5–10 years were collected from individuals for
the purpose of investigating the intrapatient genetic diversity of
HBV (Kowalec et al., 2013). All specimens were collected on
dates ranging from 1998 to 2017 (Supplementary Table 1). Viral
genomic DNA was extracted from 200 µL sera and amplified as
previously described (Bouckaert et al., 2017). Amplicons were
sequenced with an AB 3730 XL DNA analyzer using Big Dye 3.1
terminator chemistry (Thermo Fisher Scientific, Burlington, ON,
Canada). Sequences were assembled and analyzed using DNA
sequence analysis software (Lasergene software suite v 15.0.0,
DNASTAR, Madison, WI, USA).
2.2. Taxon Sampling
We created two datasets for the analysis of the Greenland taxa.
The first dataset (dataset 1) was 3,567 nucleotides in length
and included genomes larger than 2,900 nucleotides for a total
of 1,921 sequences from all HBV genotypes. This dataset was
created in order to assess the clustering of the Greenland taxa
within existing HBV diversity. Dataset 1 was subsampled to
contain only complete genomes as indicated in their NCBI record
(dataset 1.1), resulting in a dataset with 1,777 sequences and 3,510
nucleotides in length from genotypes A–F. Dataset 1 was further
subsampled for a genetic distance analysis (dataset 1.2), where
900 sequences consisting of complete genomes were used (see
Methods subsection 2.4 for details).
The second dataset (dataset 2) was 3,182 nucleotides in
length and included 93 sequences of genotype D sequences
and Greenland sequences in order to assess the diversity of
the novel sequences in a more granular way within genotype
D, following the evidence from dataset 1 that these novel
sequences fall within the genotype D clade. We kept two
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FIGURE 1 | Sampling locations of Hepatitis B virus (HBV) isolates within Western Greenland. The map was generated using Tableau Desktop 2009.1 (https://www.
tableau.com).
identical sequences which were serially collected from a single
Greenland patient with Accession IDs JN792909 sampled in
1998, and JN792910 sampled in 2004. Out of the 39 Greenland
sequences, 29 are novel and are published here for the first
time (Supplementary Table 1). Seventeen sequences cover the
full genome, while the remaining twelve are partial or nearly
complete, though at least 1,253 nucleotides in length.We selected
54 sequences to represent HBV/D history and calibrate our data
(Supplementary Table 1). Forty-two sequences serve as global
representation of all subgenotypes (D1, n = 10; D2, n = 1; D3,
n = 5; D4, n = 6; D5, n = 5; and D6, n = 5). An additional four
are “novel quasi-subgenotype D2 of hepatitis B virus” full-length
genome sequences from Taiwanese Indigenous peoples (Tran
et al., 2014 AB555496, AB555497, AB555500, and AB555501),
two are from a New Caledonia (HQ700511) and Argentina
(JN688695) outgroup to the Indigenous taxa, and six are partial
or nearly complete ancient HBV (aHBV) DNA sequences at least
943 nucleotides in length. Four aHBV sequences came from the
Mühlemann et al. (2018) study (LT992438, LT992439, LT992444,
and LT992454) and two aHBVs came from Krause-Kyora et al.
(2018) study, a German medieval tooth and an Italian mummy
available at PRJEB24921 of the European Nucleotide Archive.
The ages of these ancient sequences ranged from 281 Before
Common Era (BCE) to 1569 Common Era (CE).
The GenBank accession numbers for novel and previously
published HBV genomes for dataset 2 are included in
Supplementary Table 1.
2.3. Molecular Sequence Analyses
We computed multiple sequence alignments using MAFFT
(Katoh and Standley, 2013) under default settings. We visualized
the alignments and trimmed ragged edges with AliView (Larsson,
2014). We screened our datasets for recombination using
RDP4 (Martin et al., 2015) applying six algorithms: Geneconv,
Bootscan, MaxChi, Chimera, SiScan, and 3Seq.
The dataset 2 nucleotide alignment was translated to specific
open reading frames for the polymerase and preS2 coding
regions to determine the presence of signature amino acids
associated with HBV/D subgenotypes within the Greenland
sequences. We evaluated the amino acid residues for positions
39 (Pre-S2), 100 and 128 (POL Spacer), and 126 (RT) for all
Greenland sequences and compared the observed residues to the
predominant amino acids of subgenotypes D1 and D2, according
to Yousif and Kramvis (2013). In addition, we mapped three
distinct nucleotide mutations G1896A, A1762T, and G1764A
across all Greenland taxa, as these are important markers
associated with disease prognosis.
2.4. Genetic Distance
To calculate the genetic distance between the Greenland
clade and other subgenotypes we estimated the evolutionary
divergence over full-length genome sequence between groups
as implemented in MEGA X (Kumar et al., 2016, 2018). The
analyses were conducted using the Maximum Composite
Likelihood model (Tamura et al., 2004). This analysis
involved 900 nucleotide sequences from subgenotypes D1
(579), D2 (293), and Greenland (28) from dataset 1.2 (see
Supplementary Material). Codon positions included were 1st +
2nd + 3rd + Non-coding. All ambiguous positions were removed
for each sequence pair (pairwise deletion option). There were a
total of 3,353 positions in the final dataset.
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2.5. Phylogenetic Tree Search
To assign the novel HBV sequences from Greenland to the
correct genotype we conducted a phylogenetic tree search
on dataset 1 under the optimality criterion of maximum
likelihood with substitution model testing as available in IQ-
TREE (Nguyen et al., 2015). We executed a 1,000-replicate SH-
aLRT measure of support (Guindon et al., 2010). “The SH-aLRT
is an approximation of the likelihood ratio, a direct measure of
how much the evidence supports the hypothesis. SH-aLRT is an
approximation of the ratio of the log-likelihood of the optimal
hypothesis and the best contradictory hypothesis” (Schneider et al.,
2020).
In order to avoid any artifact or bias in the analysis, we
tested dataset 1 against its subset dataset 1.1, and no major
changes of topology were found. We also tested dataset 2 of
the novel Greenland taxa against two subsets of it: (1) only
full genomic sequences; (2) only full genomic sequences and
unique individuals (oldest sequence from each individual was
selected). We built a total of three ML trees using IQ-Tree and
compared them. Neither subset tree had a change in the overall
tree topology or affected the monophyly of the Greenland clade.
We used BEAST v1.10.4 (Suchard et al., 2018) to calculate
the TMRCA of the Greenland taxa on dataset 2 (genotype
D). Based on the partial fragmentation of our alignment (see
Supplementary Material), we elected to treat the alignment as
a single substitution partition, contrary to the eight-partition
approach used on genotype B by Bouckaert et al. (2017). We
selected the GTR+Ŵ4 substitution model with four empirical
base frequencies, a Skyride coalescent tree prior (Minin et al.,
2008), and an uncorrelated relaxed lognormal clock (URL).
We also tested a strict clock; however, we did not observe
convergence in Tracer (Rambaut et al., 2018), confirming the
URL clock as the appropriate selection. We ran the model in
duplicate with aMarkov chainMonte Carlo length of 100million.
Convergence was determined by Effective Sample Sizes of at
least 200 per statistic. The final maximum clade credibility tree
with metadata annotation was rendered using FigTree (Rambaut,
2012).
3. RESULTS
3.1. Maximum Likelihood Tree Indicates
Greenland Lineage Independence
Model testing prior to IQ-TREE building identified the best fit
model from Akaike and Bayesian Information Criterion as GTR
+ F + R10. The maximum likelihood tree from dataset 1.1 has
the Greenland taxa in a monophyletic group sister to genotype
D sequences with 89.9% SH-aLRT-like support (Figure 2). Thus,
we assigned them to genotype D for our downstream analyses.
All subsequent references to our data refer to dataset 2 containing
only genotype D sequences.
3.2. Recombination
We excluded no taxa based on recombination. RDP identified
two potential recombinants (see Supplementary Material). The
first we interpret to be false identification of the recombinant
region from nucleotide position 1720–2579 in 11 D4/D6
sequences containing an 859 base pair section from D2 sequence
AB267090. Based on the location of the areas internal and
external to the recombination site in UPGMA trees, we see no
evidence for inter-subgenotype recombination. An additional
sequence, JN792912, which was labeled as mostly recombinant
with unknown origin, was removed in addition to the eleven
sequences and RDP was re-run. The same region was identified
in all D3 sequences instead of D4/D6 with a supposed D1 parent.
We hypothesize this is an artifact given the high nucleotide
conservation of this region. The UPGMA tree topologies were
not suspicious of recombinant template-switching in these taxa.
The second recombinant region flagged by RDP was in an
Indian D5 sequence, GQ205382, with a 269 base pair region of
a D3 sequence (KX827292) from nucleotides 1765 to 2034. This
region has no mutations between the two sequences. Instead, the
D3-specific single nucleotide polymorphisms (SNPs) are found
in this D5 sequence, potentially representing a recombination
event that cannot be excluded. However, the D5 sequence still
clusters with other Indian D5 sequences in a clade with 100% SH-
aLRT-like support in the ML tree. Neither of these taxa produced
interference on ML tree topology. Thus, we elected to keep all of
the 93 taxa. We found no recombination between D1, D2, and
the Greenland sequences.
3.3. Amino Acid Signatures
The Greenland HBV/D amino acid signatures on Pre-S2 aa39,
POL Spacer aa100 and aa128, and RT aa126 introduces a
paradigm in relation to D1 and D2 signatures (Table 1).
The Greenland sequences do not “fit” into either D1 or D2
subgenotypes amino acid signatures predominantly observed
with these subgenotype sequences according to Yousif and
Kramvis (2013). Instead, they share characteristics of D2 at PreS2
aa39 and POL aa100, and D1 at RT aa126 and POL aa128.
3.4. Mutations
We observed mutations in our sequences at positions 1762 (wild
type A; mutant T), 1764 (wild type G; mutant A), and 1896
(wild type G; mutant A). Twenty two of the 39 Greenland
sequences had a G to A mutation at nucleotide position 1896.
Of the 13 consecutively sampled taxa, only two pairs reflected
this substitution, whereas most (n = 5) had a mutant A at
position 1896 in both samples. Mutations A1762T and G1764A
were not as prevalent, present in only 9/39 and 14/39 Greenland
sequences, respectively (Table 2).
3.5. Genetic Distance
TheGreenland clade had an estimated evolutionary divergence of
∼3% with both subgenotypes D1 and D2. Both D1 and D2 also
shown a divergence of ∼3% between each other (Table 3). We
used the pool of complete genome sequences of the Greenland
clade and compared to the pool of D1 and D2 sequences
belonging to sister clades on the ML tree.
3.6. Substitution Rate and TMRCA of
HBV/D in Greenland Populations
We inferred on the molecular clock analysis a substitution rate
of 1.398 × 10−5 [95% HPD 8.837 × 10−6, 1.952 × 10−5],
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FIGURE 2 | Phylogenetic hypothesis of dataset 1.1. Maximum-likelihood tree. Branch lengths represent an estimation of the average number of nucleotide
substitutions per site. Node labels indicate SH-aLRT support. Clade names correlate to their genotype assignment and are represented by the vertical bars on the
right of the tree. Red collapsed clade represents the Greenland taxa. See Supplementary Material for a full version of this tree.
TABLE 1 | Amino acid signatures of HBV subgenotype D1, D2 and Greenland
taxa.
AA Signature D1 D2 Greenland
Pre-S2 aa39 V/a A/v A
POL Spacer aa100 S/a, t A/t,v A
POL Spacer aa128 S/g G/s S
RT aa126 H R/h H
Adapted from Yousif and Kramvis (2013).
similar to that obtained by Mühlemann et al. (2018): 1.18× 10−5
[9.21 × 10−6, −1.45 × 10−5]. The age of the root, representing
genotype D, was 675 BCE (1221 BCE, 281 BCE). The age of
the Greenland taxa was 629 CE (95% HPD interval 37 CE,
1138 CE).
4. DISCUSSION
Studies on HBV phylogenetics provide a means of understanding
the history of the disease spread in an epidemiological context.
In this study, we reveal a novel quasi-subgenotype of HBV
genotype D isolated from Greenland. Interestingly, this novel
clade, sister to subgenotype D2, shares genetic characteristics
of both subgenotypes D1 and D2 and shares slightly reduced
genetic divergence with subgenotype D1 (3.1%) compared to
subgenotype D2 (3.2%) based on our data. Inference of all
Greenland taxa as monophyletic in maximum likelihood and
Bayesian frameworks supports the hypothesis of a single origin
event giving rise to a distinct and isolated lineage on the west
coast of Greenland.
Phylogeography in the Greenland dataset was not used given
the limited geographic scope of the Greenland taxa and lack
of logistical purpose exploring global movement given our
reductive representation of genotype D taxa. The 1762 and
1764 site mutations are associated with a significantly increased
risk of liver disease progression and hepatocellular carcinoma
development (Yang et al., 2016; Lin and Kao, 2017). The
mutation on site 1896 is associated with HBeAg negativity and
seroconversion to anti-HBeAg positivity by introducing a stop
codon to the HBeAg reading frame (Kramvis et al., 2018).
Twenty two of the Greenlandic sequences shared a non-exclusive
G to A substitution at nucleotide position 1896, associated
with seroconversion of positive HBeAg reactivity to anti-HBeAg
positivity and historically most present in genotype D (Zhand
et al., 2015). These taxa likely had higher rates of evolution
(Kramvis et al., 2018), though our methods were unable to
tease apart their contribution to the substitution rate. Of our
consecutively sampled pairs/triplet, the lack of precore mutation
(n = 3) or substitution from the mutant to the wild type (n
= 3) indicates active infection occurring over multiple years,
though our lack of sampling only offers sporadic glances into
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TABLE 2 | Greenland HBV/D taxa and consecutive paired sera.
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TABLE 3 | Estimates of evolutionary divergence over sequence pairs between
Greenland, D1 and D2 clades.
Greenland D1 D2
Greenland 0 0.0309 0.0322
D1 0.0309 0 0.0303
D2 0.0322 0.0303 0
The number of base substitutions per site from averaging over all sequence pairs between
groups are shown.
infection dynamics. The identical pair of consecutively sampled
sera separated by 6 years is interesting, as we expected this
individual to seroconvert over this period. These findings reflect
the slow and tangled nature of HBV evolution.
As the Greenland sequences are monophyletic, this suggests
the presence of a lineage with a new amino acid signature. For
instance, though no recombination was inferred between the
Greenland sequences and subgenotype D1/D2, the overlapping
serotype signatures (Table 1), suggest that the Greenland taxa
cannot be neatly fit into the amino acid composition of
either subgenotype.
It is a well-known observation that subgenotype D1
shows intergroup divergence with D2 <4–7.5% divergence
agreed upon as the definition of an HBV subgenotype
(Yousif and Kramvis, 2013; McNaughton et al., 2020). The
justification for classifying D1 and D2 as subgenotypes is based
upon well-resolved phylogenetic clustering, supported by high
bootstrap values (>85–90%), different serological subtypes, and
different geographic distribution (Yousif and Kramvis, 2013).
As observed in this study, the Greenland HBV clade is well-
resolved and clusters completely separately with high confidence
by aLRT-SH and posterior probability, and is unique to the
geographic region of Greenland. However, in keeping with the
suggestion of McNaughton et al. (2020), the Greenland clade
may be considered a quasi-subgenotype due to its monophyletic
clustering following maximum-likelihood analysis but with a
genetic distance separating it from D2 and D1 of ∼3%. Based
on tree topology, this quasi-subgenotype clusters most closely
with HBV subgenotype D2. The Greenland taxa’s inferred sister
clade, which includes HBV subgenotype D2 from Taiwanese
Indigenous Peoples, New Caledonia, and Argentina, suggests a
single origin between the Greenland and D2 taxa that is not
inclusive of D1, with 94% posterior support (Figure 3).
Taxa are likely to be geographically related, preserving
the complication that may be faced with pure geographic
assignment (de Bernardi Schneider et al., 2019; Mojsiejczuk
et al., 2020). Rather than focusing on endemicity, location,
or solely genetic distance, the best way to characterize HBV
may be by observing evolutionarily independent lineages
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FIGURE 3 | Phylogenetic hypothesis of dataset 2. HBV/D Maximum Clade Credibility (MCC) tree from combined run trees with posterior support indicated on nodes.
Greenland lineages are shaded in red and corresponding location indicated by colored circle on branch tips. X-axis represents the age of nodes.
through phylogenetic analysis, as is argued by Peterson (2014).
Phylogenetic analysis circumvents the use of genetic distance as
a sole metric for sub-/geno-type naming. Further, while genetic
distances between the Greenland taxa and subgenotypes D1 and
D2 (3.1 and 3.2%, respectively) are within what McNaughton
et al. (2020) cites as the majority of genotype D pairwise distance
(i.e., 2–4%, compared to the typical subgenotype divergence of
3–8%), they are also distinctly monophyletic across our methods.
Here, we present our inference of 39 Greenland HBV/D taxa
as a newly characterized quasi-subgenotype exemplified by this
topologically independent lineage.
The Greenland taxa’s TMRCA of 629 CE translates to a
coalescence point about 1,390 years before present (YBP),
preceding the only other Greenland HBV lineage (B5) studied
(Bouckaert et al., 2017). Their study estimated that B5 was
introduced to Greenland during coastal route movement of the
Thule in the last 1,000 years (Bouckaert et al., 2017), calibrated
by the date associated with Thule migration to the Eastern
Arctic (647–953 YBP or 1370–1064 CE). Nonetheless, they are
distinct genotypes evolving at different rates, thus it is feasible
that these genotypes arrived in Western Greenland following
separate introductions.
The more closely related subgenotype D2 may have an
origin from the Middle East (Kostaki et al., 2018) or Southern
Europe (Spitz et al., 2019). The use of ancient HBV DNA
allowed us to estimate a Greenland HBV/D TMRCA range of
37–1138 CE. Similar to what has been described with HBV
genotype B-infected indigenous people in the circumpolar Arctic
(Bouckaert et al., 2017), this result suggests that the virus was
introduced at some point to the Thule, but this ancestor no longer
exists. However, ancestral remnants aside from the Taiwanese
Indigenous and New Caledonian samples which formed an
adjacent clade to the Greenland taxa are necessary for improved
confidence in inferring the route which brought HBV/D to
these populations.
Integrating novel sequences with published HBV/D data
in this study has demonstrated a strongly inferred and
geographically independent monophyletic lineage from existing
HBV/D subgenotype architecture. We reveal that HBV/D
samples from 25 Western Greenland residents, 13 of whom were
consecutively sampled over 5–10 years, form an evolutionarily
unique clade distinct from subgenotypes D1 and D2.
Pairing these modern data with ancient DNA, we uncovered
more detail in the story of HBV genotype D evolution. Such
diachronic studies are necessary for the tough-to-interpret HBV
(Mühlemann et al., 2018), where study results on rate and
origin vary by orders of magnitude subjective to data and
model limitations. Additional HBV/D sequences from ancient
archeological remains in the Arctic are necessary to resolve the
mystery of its origin and pattern of dispersal beyond speculation.
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